Literature DB >> 9652194

A review of direct current cardioversions for atrial arrhythmia.

S D Johnston1, T G Trouton, C Wilson.   

Abstract

UNLABELLED: The risk of arterial embolism is well recognised following Direct Current Cardioversion (DCC) for atrial fibrillation although the use of prophylactic anticoagulation remains controversial. AIM: To determine the risk of arterial embolism post-cardioversion and which factors predict successful cardioversion and maintenance of sinus rhythm.
MATERIALS AND METHODS: A retrospective study was carried out of all cardioversions performed for atrial fibrillation and atrial flutter at the Waveney Hospital Ballymena, during 1989-1993. A review of medical records and electrocardiograms was carried out to assess demographic characteristics, co-existent diseases, anticoagulant status, echocardiographic features and characteristics of the arrhythmia. Embolic events in the six weeks post-cardioversion were noted.
RESULTS: The study included 157 cardioversions in 109 patients. The predominant arrhythmia was atrial fibrillation (n = 108, 69%). Three of 109 patients (2.7%) experienced embolic complications, none of whom had anticoagulation prior to the procedure. No risk factors for cerebro-vascular disease or significant valvular heart disease were present. Return to sinus rhythm was achieved in 143 (91%) procedures. Increasing coarseness of atrial fibrillation was associated with a non-significant trend towards successful restoration of sinus rhythm (p = 0.18). Recurrence of the original arrhythmia was predicted by an increase in coarseness of atrial fibrillation (p < 0.05).
CONCLUSIONS: These findings indicate that embolic complications can occur in patients undergoing DCC with normal echocardiographic dimensions, and that prophylactic anticoagulation should be considered in all patients. Coarseness of atrial fibrillation may be used as a guide to predict the chance of successful cardioversion and of the likelihood of maintaining sinus rhythm once this has been achieved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652194      PMCID: PMC2448669     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  16 in total

Review 1.  Antithrombotic therapy in atrial fibrillation.

Authors:  M Dunn; J Alexander; R de Silva; F Hildner
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

2.  Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation.

Authors:  H C Dittrich; J S Erickson; T Schneiderman; A R Blacky; T Savides; P H Nicod
Journal:  Am J Cardiol       Date:  1989-01-15       Impact factor: 2.778

Review 3.  Atrial fibrillation and stroke: new ideas, persisting dilemmas.

Authors:  J L Halperin; R G Hart
Journal:  Stroke       Date:  1988-08       Impact factor: 7.914

4.  Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation.

Authors:  W J Manning; D E Leeman; P J Gotch; P C Come
Journal:  J Am Coll Cardiol       Date:  1989-03-01       Impact factor: 24.094

5.  The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation.

Authors:  C J Bjerkelund; O M Orning
Journal:  Am J Cardiol       Date:  1969-02       Impact factor: 2.778

6.  An evaluation of DC shock treatment of atrial arrhythmias.

Authors:  C Bjerkelund; O M Orning
Journal:  Acta Med Scand       Date:  1968-12

7.  Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up.

Authors:  C McCarthy; P J Varghese; D W Barritt
Journal:  Br Heart J       Date:  1969-07

8.  Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success.

Authors:  G B Mancini; A L Goldberger
Journal:  Am Heart J       Date:  1982-09       Impact factor: 4.749

9.  Electrical reversion of cardiac arrhythmias.

Authors:  B Lown
Journal:  Br Heart J       Date:  1967-07

10.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

View more
  2 in total

1.  The outcome of direct current cardioversion (DCC) for the treatment of atrial fibrillation (AF) in a district general hospital in Ireland.

Authors:  K P O'Rourke; C Cotter; D Mullane; P Thorpe; P Sullivan
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

2.  Randomised comparison of electrode positions for cardioversion of atrial fibrillation.

Authors:  T P Mathew; A Moore; M McIntyre; M T Harbinson; N P Campbell; A A Adgey; G W Dalzell
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.